Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot pharmacokinetic and safety evaluation of darunavir/ritonavir plus etravirine in treatment-experienced HIV-1-infected subjects
2005-003841-14Phase 2Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of darunavir, ritonavir and etravirine in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Primary endpoint: Steady-state pharmacokinetics of darunavir/ritonavir and etravirine when co-administered. Started Sep 2005; status: completed.
02
Drugs
darunavirritonaviretravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-003841-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003841-14.